Terra Tech Corp. (TRTC) Stock Analysis
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Terra Tech Corp. (TRTC) trades at $0.2738 with AI Score 41/100 (Grade C). Terra Tech Corp. cultivates, produces, and retails medical and adult-use cannabis products, operating through herbs and produce, cannabis dispensary, and real estate/construction segments. Sector: Healthcare.
Price as of Aug 21, 2026 · Last analyzed: Mar 17, 2026Analyst Coverage for TRTC: TRTC does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates TRTC against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
TRTC: 2/3 scored disciplines lean bearish. Dominant signal: Ray Dalio bullish.
How is this calculated? →Why this analysis is different
- A 9-signal quantitative MoonshotScore built from filings, insider activity, and market data — computed from the numbers, not from opinion.
- An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
- Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.
Terra Tech Corp. (TRTC) Healthcare & Pipeline Overview
Terra Tech Corp. operates in the cannabis and hydroponic produce sectors, cultivating, producing, and retailing cannabis products under the Blüm and IVXX brands, alongside hydroponic herbs and real estate ventures. The company faces challenges in a competitive market while navigating regulatory complexities and striving for profitability.
What Is the Investment Thesis for TRTC?
Terra Tech Corp. operates in the rapidly growing cannabis market, but its financial performance raises concerns. The company's negative P/E ratio of -0.96 and a substantial negative profit margin of -210.8% indicate significant challenges in achieving profitability. While the gross margin of 25.2% suggests some efficiency in production, it's insufficient to offset operating expenses. Growth catalysts include expansion of cannabis operations in California and Nevada and potential regulatory changes that could increase market access. However, the company faces risks related to competition, regulatory uncertainty, and the need for additional capital. The high beta of 2.28 indicates high volatility, making it a speculative investment.
Based on FMP financials and quantitative analysis
TRTC Key Highlights
Operates in three segments: Herbs and Produce Products; Cannabis Dispensary, Cultivation and Production; and Real Estate and Construction.
- Operates medical and adult use dispensaries under the Blüm brand.
- Produces and sells cannabis products under the IVXX brand.
- Gross Margin of 25.2% indicates potential for profitability if operating expenses are managed effectively.
- Beta of 2.28 suggests high volatility compared to the overall market.
Who Are TRTC's Competitors?
TRTC is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| BIOGF Biocartis Group N.V. | $0.66 | -85.33% | $65.4M | 52 |
| EEOIF Elegance Optical International Holdings Limited | $0.07 | +0.00% | $63.4M | 46 |
| EOFBY Ecofibre Limited | $0.84 | +0.00% | $73.7M | 40 |
| GDNSF Goodness Growth Holdings, Inc. | $0.45 | +0.00% | $61.1M | 64 |
| HRPMF Herantis Pharma Oyj | $3.51 | +0.00% | $59.5M | 44 |
| ZTS Zoetis Inc. | $75.44 | -1.62% | $31.6B | 85 |
| ITCI ITCI | $131.87 | +0.00% | $14.1B | 63 |
| ESALF Eisai Co., Ltd. | $29.90 | +0.00% | $8.44B | 61 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are TRTC's Key Strengths?
Established brands (Blüm and IVXX).
- Vertical integration.
- Expertise in hydroponics.
- Diversified operations (cannabis, herbs, real estate).
What Are TRTC's Weaknesses?
Negative profitability.
- High debt levels.
- Dependence on regulatory approvals.
- Limited geographic reach.
What Could Drive TRTC Stock Higher?
Potential regulatory changes in California and Nevada that could expand market access.
- Expansion of cannabis cultivation and production capacity.
- Development and launch of new cannabis products.
- Strategic partnerships and acquisitions to expand market reach.
What Are the Key Risks for TRTC?
Negative return on equity (-48.3%) — the business is not currently generating profit on shareholder capital.
- Intense competition in the cannabis industry.
- Regulatory uncertainty and changing state laws.
- Fluctuations in cannabis prices.
- Difficulty in accessing capital.
- Negative profitability and high debt levels.
What Are the Growth Opportunities for TRTC?
- Expansion of Cannabis Operations in California and Nevada: Terra Tech can capitalize on the growing cannabis markets in California and Nevada by expanding its cultivation, production, and retail operations. Increased cultivation capacity and strategic dispensary locations could drive revenue growth. The California cannabis market is projected to reach $7 billion by 2026, while Nevada's market is expected to exceed $1 billion. Timeline: Ongoing.
- Product Innovation and Development: Introducing new and innovative cannabis products, such as edibles, concentrates, and topicals, can attract new customers and increase market share. Developing unique formulations and branding strategies can differentiate Terra Tech from competitors. The market for cannabis-infused products is expanding rapidly, with edibles and concentrates gaining popularity. Timeline: Ongoing.
- Strategic Partnerships and Acquisitions: Forming strategic partnerships with other cannabis companies or acquiring complementary businesses can expand Terra Tech's reach and capabilities. Partnerships with established brands or technology providers can enhance product offerings and improve operational efficiency. The cannabis industry is consolidating, with companies seeking to gain scale and market presence through mergers and acquisitions. Timeline: Ongoing.
- Development of Proprietary Cannabis Strains: Terra Tech can invest in research and development to create proprietary cannabis strains with unique characteristics and therapeutic benefits. Developing and patenting new strains can provide a competitive advantage and generate higher margins. The demand for specialized cannabis strains is increasing as consumers seek specific effects and experiences. Timeline: 2-3 years.
- Focus on Hydroponic Herbs and Produce: Terra Tech can leverage its expertise in hydroponics to expand its herbs and produce business. Growing high-quality, locally sourced herbs and leafy greens can cater to health-conscious consumers and generate a stable revenue stream. The market for hydroponically grown produce is growing, driven by increasing demand for sustainable and locally sourced food. Timeline: Ongoing.
What Are TRTC's Competitive Advantages?
- Brand recognition through the Blüm and IVXX brands.
- Vertical integration across cultivation, production, and retail.
- Expertise in hydroponic cultivation techniques.
- Real estate holdings in strategic locations.
What Does TRTC Do?
Founded in 2010 and headquartered in Irvine, California, Terra Tech Corp. operates as a diversified cannabis company with interests spanning cultivation, production, and retail. The company initially focused on providing agricultural technology solutions before pivoting to the cannabis industry. Terra Tech operates through three segments: Herbs and Produce Products, Cannabis Dispensary, Cultivation and Production, and Real Estate and Construction. Its Herbs and Produce segment offers hydroponically grown herbs and leafy greens. The Cannabis Dispensary, Cultivation and Production segment operates medical and adult-use dispensaries under the Blüm brand, offering cannabis flowers, concentrates, and edibles. The company also produces and sells cannabis products under the IVXX brand, including flowers, oils, waxes, shatters, and clears. Additionally, Terra Tech engages in real estate and construction activities related to cannabis facilities. The company's geographic focus is primarily in California and Nevada.
What Products and Services Does TRTC Offer?
- Cultivates medical and adult-use cannabis.
- Produces cannabis-infused products, including edibles and topicals.
- Operates medical marijuana retail and adult-use dispensaries under the Blüm brand.
- Sells a line of medical and adult-use cannabis flowers, oils, waxes, and concentrates under the IVXX brand.
- Engages in real estate and construction activities related to cannabis facilities.
- Offers hydroponic herbs and leafy greens products.
How Does TRTC Make Money?
- Cultivation and production of cannabis products.
- Retail sales through company-owned dispensaries.
- Wholesale distribution of cannabis products to other retailers.
- Real estate and construction services for cannabis facilities.
What Industry Does TRTC Operate In?
Terra Tech Corp. operates within the evolving cannabis industry, which is experiencing rapid growth and increasing legalization across various states. The market is characterized by intense competition, with numerous players vying for market share. Regulatory hurdles and varying state laws create complexities for cannabis companies. Terra Tech competes with other cannabis producers, distributors, and retailers, including BIOGF (BioHarvest Sciences Inc.), EEOIF (Empower Clinics Inc.), EOFBY (EnWave Corporation), GDNSF (GrowGeneration Corp.), and HRPMF (Harborside Inc.). The industry is subject to changing consumer preferences, technological advancements in cultivation and production, and ongoing regulatory developments.
Who Are TRTC's Key Customers?
- Medical marijuana patients.
- Adult-use cannabis consumers.
- Wholesale customers (other cannabis retailers).
- Real estate clients (cannabis businesses).
Key Financial Metrics
Return on equity for Terra Tech Corp. stands at -48.3%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -30.0%, showing how much profit it generates from its asset base. A current ratio of 1.42 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is -103.7%, the inverse of the P/E and a quick read on earnings relative to price.
TRTC Valuation & Market Position
Relative to its peer group, TRTC's quantitative score of 41/100 is roughly in line with the peer average of 49/100.
Company Profile
Terra Tech Corp. operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in Irvine, US. The company is led by CEO Derek A. Peterson. TRTC has traded publicly since 2012.
TRTC Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Established brands (Blüm and IVXX).
- Vertical integration.
- Expertise in hydroponics.
- Diversified operations (cannabis, herbs, real estate).
Bear Case
- Negative profitability.
- High debt levels.
- Dependence on regulatory approvals.
- Limited geographic reach.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · August 2026
TRTC Latest News
No recent news available for TRTC.
TRTC Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for TRTC.
Price Targets
Wall Street price target analysis for TRTC.
TRTC MoonshotScore
What does this score mean?
The MoonshotScore rates TRTC 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.
Leadership: Derek A. Peterson
CEO
Derek A. Peterson serves as the CEO of Terra Tech Corp. His background includes experience in the financial services and technology sectors. Prior to joining Terra Tech, Peterson held various leadership positions in investment banking and venture capital firms. He has a track record of advising and investing in emerging growth companies. Peterson's expertise spans corporate finance, strategic planning, and business development.
Track Record: Under Derek A. Peterson's leadership, Terra Tech Corp. has expanded its operations in the cannabis industry, focusing on cultivation, production, and retail. Key milestones include the acquisition of cannabis dispensaries and cultivation facilities, as well as the development of the IVXX brand. Peterson has also overseen the company's efforts to navigate regulatory challenges and secure licenses in various states.
TRTC OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Terra Tech Corp. may not meet the minimum financial standards or reporting requirements for higher tiers like OTCQX or OTCQB. Companies in this tier may have limited information available to investors and are often considered more speculative due to the lack of regulatory oversight and financial transparency compared to NYSE or NASDAQ-listed companies. Investing in OTC Other stocks carries significant risks due to the potential for fraud, manipulation, and lack of liquidity.
- OTC Tier: OTC Other
- Limited financial disclosure.
- Low trading volume and liquidity.
- Potential for fraud and manipulation.
- Lack of regulatory oversight.
- Higher price volatility.
- Verify the company's financial statements and SEC filings (if any).
- Research the company's management team and their track record.
- Assess the company's business model and competitive landscape.
- Evaluate the company's legal and regulatory compliance.
- Review the company's capitalization structure and ownership.
- Check for any red flags or warning signs.
- Consult with a qualified financial advisor.
- Company has been in operation for over 10 years.
- Operates physical retail locations under the Blüm brand.
- Has a diversified business model across cannabis, herbs, and real estate.
- CEO has experience in financial services and technology.
- Company has secured licenses to operate in multiple states.
Terra Tech Corp. Healthcare Stock: Key Questions Answered
What does the AI Score mean for TRTC?
TRTC holds an AI Score of 41/100 (Grade: C). This is an educational research signal, not a buy or sell recommendation. Terra Tech Corp. cultivates, produces, and retails medical and adult-use cannabis products, operating through herbs and produce, cannabis dispensary, and real estate/construction segments. …
What does Terra Tech Corp. do?
Terra Tech Corp. is a vertically integrated cannabis company that cultivates, produces, and retails medical and adult-use cannabis products. The company operates through three segments: Herbs and Produce Products; Cannabis Dispensary, Cultivation and Production; and Real Estate and Construction.
What are the main risks for TRTC?
Terra Tech Corp. faces several risks, including intense competition in the cannabis industry, regulatory uncertainty and changing state laws, fluctuations in cannabis prices, difficulty in accessing capital, negative profitability, and high debt levels. The company's reliance on regulatory approvals and licenses also poses a risk.
What revenue streams does Terra Tech Corp. have in healthcare?
Terra Tech Corp.'s primary revenue streams in the healthcare sector come from the sale of medical and adult-use cannabis products through its Blüm dispensaries and the IVXX brand. These products include cannabis flowers, concentrates, edibles, and topicals. The company generates revenue from both retail sales to consumers and wholesale distribution to other retailers.
How does Terra Tech Corp.'s vertical integration strategy impact its profitability?
Terra Tech Corp.'s vertical integration strategy, encompassing cultivation, production, and retail, aims to improve profitability by controlling the entire supply chain and reducing reliance on external suppliers. By cultivating its own cannabis, the company can potentially lower production costs and ensure product quality. Operating its own dispensaries allows Terra Tech to capture retail margins and maintain direct relationships with customers.
What are the key factors to evaluate for TRTC?
Terra Tech Corp. (TRTC) holds an AI score of 41/100 (low). operates in the rapidly growing cannabis market, but its financial performance raises concerns. Not financial advice.
How frequently does TRTC data refresh on this page?
TRTC's price was last updated on Aug 21, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven TRTC's recent stock price performance?
Terra Tech Corp. (TRTC) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Established brands (Blüm and IVXX). See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider TRTC overvalued or undervalued right now?
Terra Tech Corp. (TRTC) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- AI analysis pending for TRTC. Financial data based on available information.